Most Advanced Immune System Support*

Nearly all environmental threats contain proteins that the immune system must identify and break down. Enzymes that break down protein (proteolytic) can support this immune process.*

Enzyme Defense™ Extra Strength is 2x the potency of Enzyme Defense™

• Provides support to purify the body*
• Assists in removing proteins that do not belong in the bloodstream.*
• Naturally help break down excess mucus* 
• Promotes healthy circulation*

Usage & Notes

Recommended Use: 1 capsule twice daily on an empty stomach, one hour before or two hours after a meal.

Enzyme Defense is not an “immune stimulator,” rather a supporter of healthy immune function.*

Enzymedica does not use ingredients produced using biotechnology.

Consult with a physician prior to use if pregnant or nursing.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. 

Enzyme Defense™ Extra Strength is an improved version of Enzyme Defense. The enhanced formula contains a 60% increase of Serrapeptase (also known as Serratiopeptidase).

Enzymes can break down undigested food protein, cellular debris, and proteins that don’t belong in the bloodstream.*

Oral proteases, taken as a dietary supplement on an empty stomach, are absorbed and carried into the bloodstream where they are bound to plasma proteins known as Alpha-II-macroglobulin.(1)*

Recent research also indicates that the oral proteases bound to these plasma proteins can help break down harmful protein-based invaders in the blood.(2)*

The unique Enzyme Defense formula helps break down protein intruders in the bloodstream.*

• Protease
• Catalase
• Mucolase™
• Serrapeptase

These enzymes exhibit powerful antioxidant properties to help neutralize free radicals, digest mucus, encourage healthy circulation, and support systemic health.*

References

1 Muller, Lauer D. “Modulation of growth factor binding properties of alpha2-macroglubin by enzyme therapy.” Cancer Chemother Pharmacol. 47.Suppl 1 (2001): S4-9

2 Holomanova, Desser L. “Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.” Cancer Chemother Pharmacol. 47. Suppl 1 (2001): S10-5